15.2 DLCO & Exercise Test Reliability
Key Takeaways
- DLCO reliability (III.B.5) hinges on inspired volume vs VC, breath-hold quality/timing, alveolar sample integrity, and recognition of COHb and related confounders.
- A mathematically complete DLCO printout is unreliable if VI/VC is inadequate, BHT is wrong, or the sample is contaminated by dead-space or leak.
- Exercise and field-walk reliability (III.B.6–7) requires protocol adherence, valid SpO2 (motion/perfusion), measured course distance, and appropriate practice walks.
- Home testing (III.B.8) expands access but weakens unsupervised effort, environment, and device-quality controls—report and interpret with those limits explicit.
- When DLCO or walk metrics are technically compromised, retest or qualify the report; do not treat artifact as diffusion defect or true exertional desaturation.
DLCO Reliability Is More Than a Green Checkmark
After Domain II acceptability for single-breath DLCO, III.B.5 asks whether the reported diffusing capacity is reliable enough for clinical use. CO uptake numbers are sensitive to inspired volume, breath-hold timing, gas sample purity, and blood CO/hemoglobin state. An RPFT who only glances at “DLCO % predicted” without those checks will mislabel technical failure as interstitial disease—or miss a real diffusion defect hidden under a short breath-hold.
Core DLCO Reliability Checks
Inspired volume relative to VC (VI/VC)
The patient must inspire a large fraction of vital capacity so alveolar volume and CO distribution represent the lung being tested.
| VI/VC situation | Reliability implication | Typical action |
|---|---|---|
| VI clearly adequate vs concurrent VC | Supports usable VA/DLCO | Proceed if other criteria met |
| VI substantially below expected VC fraction | Under-inspiration; DLCO/VA may be biased | Recoach full inspiration; repeat |
| VC itself unreliable (incomplete spirometry) | VI/VC ratio loses meaning | Fix spirometry effort first |
| Leak during inspiration | Inspired volume false | Reject trial |
Exam stems often pair a “low DLCO” with a tracing showing small inspired volume and weak effort—reliability answer is retest, not pulmonary fibrosis narrative.
Breath-hold time (BHT)
BHT must match the method’s timing definition (ATS/ERS-aligned start/end rules used by the instrument and SOP). Too short or too long, or an unsteady hold with Valsalva/Müller straining, undermines the single-breath model.
Unreliable BHT patterns:
- Patient exhales early or inhales during “hold”
- Glottic leak (CO/tracer continuum unstable)
- Extreme pressures (strain) altering pulmonary blood volume
- Software BHT outside acceptable window with no override justification
Alveolar sample quality
DLCO depends on analyzing alveolar gas, not dead-space–heavy early gas or room-air contamination.
| Sample problem | Effect | Reliability response |
|---|---|---|
| Inadequate washout volume before sample | Dead-space contamination → erroneous FA_CO/FA_tracer | Reject; adjust discard/sample volumes per standards/SOP |
| Leak at mouthpiece during hold/exhalation | Tracer/CO dilution errors | Reject; reseat; repeat |
| Analyzer lag/mis-timing | Wrong portion of exhalate | Service/method check; do not average bad samples |
| Water/CO2 handling faults | Biased analyzer readings | Equipment QC path |
COHb and related confounders
Carboxyhemoglobin from smoking or CO exposure occupies Hb binding sites and alters measured DLCO. Reliability judgment includes:
- Documented smoking/vaping timing relative to test
- Measured COHb (when available) and appropriate correction/reporting practice per lab standards
- Anemia/polycythemia (Hb) affecting CO uptake—often corrected in reporting but still part of reliability/context
- Recent supplemental O2 affecting comparison to room-air reference conditions
A low DLCO in a patient who smoked immediately before testing is not automatically ILD until COHb and maneuver quality are addressed. Conversely, normal-looking DLCO with high COHb may still be clinically misleading without correction notes.
Replicate agreement
Within-session DLCO trials should cluster. Large scatter after several attempts means low reliability even if one value looks “pretty.” Prefer standards-aligned averaging rules only among acceptable trials.
Exercise & Field-Walk Reliability (III.B.6–7)
Exercise and walking tests produce distance, symptoms, SpO2, heart rate, and sometimes BP/ECG. Reliability fails when the protocol or sensors fail—even if the patient “tried hard.”
Protocol adherence
| Element | Unreliable if… | Why it matters |
|---|---|---|
| Timing (e.g., 6 minutes) | Clock wrong; early stop undocumented | Distance not comparable |
| Instructions / encouragement | Inconsistent scripting | Effort and distance shift |
| Supplemental O2 policy | FiO2 changes mid-walk without plan | SpO2/distance uninterpretable vs prior |
| Workload steps (CPET/treadmill) | Stage skips, speed errors | Metabolic comparisons invalid |
| Stop criteria | Continue through unsafe symptoms or stop without reason codes | Safety + data integrity |
Oximeter reliability (motion & perfusion)
Pulse oximeters during walking are vulnerable to motion artifact, poor perfusion, ambient light, and probe placement.
Suspect SpO2 unreliability when:
- Pulse rate from oximeter disagrees with ECG/palpated rate
- SpO2 jumps erratically without physiologic pattern
- Cold fingers, nail coatings, or probe repeatedly reseated mid-test
- Patient clenches probe hand on walker/treadmill rail
Reliable practice: optimize probe site before start, confirm pulse agreement, treat wild SpO2 swings as artifact until proven, and document signal quality. Do not report a dramatic “desaturation” from a single motion-glitch nadir without waveform/pulse corroboration.
Practice walks and learning effect
A first 6MWT often underestimates true distance because of unfamiliarity. Standards commonly support a practice consideration or standardized repeat strategy. Reliability of “best distance” depends on whether the lab’s protocol for practice/repeat was followed and documented. Comparing today’s first-ever walk to last year’s third walk without noting learning effect is a reliability trap.
Course measurement errors
Distance is only as good as the course.
| Error | Effect |
|---|---|
| Unmeasured or guessed corridor length | Systematic bias in meters/feet |
| Turns counted inconsistently | Random error, poor serial comparison |
| Different course than prior visit | False improvement/decline |
| Obstacles / busy hallway stops | Nonphysiologic distance limits |
Exam answer when distance “falls 80 m” but the lab moved from a 30 m to an unmarked short hallway: question reliability of the comparison before declaring clinical worsening.
Home Testing Reliability Limitations (III.B.8)
Home spirometry and related remote testing improve access and serial sampling frequency, but reliability is constrained:
- Unsupervised effort — no real-time flow-volume coaching by an RPFT
- Device quality & calibration state — consumer/home sensors may lack full lab QC
- Environment — posture, nose clip use, distractions, illness day effects
- Maneuver selection — software may auto-pick peaks the patient cannot validate
- Context gaps — medication timing, smoking, recent exercise often incomplete
Reliability posture for the exam: Home data can trend and screen, but discordant or decision-critical values usually need laboratory confirmation. Reports should state unsupervised limitations rather than treat home FEV1 as identical in authority to a standards-aligned lab session.
Integrated Exam Scenarios
DLCO scenario: VI is 55% of measured VC, BHT short with leak flags, patient smoked 20 minutes prior, DLCO 45% predicted. Reliability: Do not lock in severe diffusion defect; correct process (inspiration, hold, COHb/timing) and retest.
Walk scenario: 6MWT SpO2 falls to 82% for two seconds while oximeter HR is 40 bpm and ECG shows 118 bpm; distance protocol correct. Reliability: SpO2 nadir is motion/perfusion artifact until a stable probe agrees with pulse; do not treat 82% as proven desaturation.
Home scenario: Home FEV1 drops 400 mL overnight; lab spirometry next day is repeatable and near baseline with good peaks. Reliability: Weight the supervised session higher; investigate home effort/device factors.
Workflow Checklist (III.B.5–8)
- DLCO: VI/VC → BHT → sample/leak → replicate agreement → COHb/Hb/O2 context.
- Exercise/walk: protocol clock & coaching → course length → practice-walk policy → SpO2 pulse agreement → symptom scores documented.
- Home: label limitations; confirm critical decisions in lab when stakes are high.
- If any pillar fails: retest or qualify—never silently convert technical failure into a disease label.
Mastering these reliability gates is what Domain III.B scores: not recalling the DLCO formula alone, but knowing when the formula’s inputs were never trustworthy.
Which combination most clearly makes a low single-breath DLCO unreliable pending retest?
During a 6-minute walk, SpO2 briefly reads 80% while the oximeter pulse rate is 48 bpm and simultaneous ECG heart rate is 120 bpm. What is the best reliability action?
A lab compares this year’s 6MWT distance to last year’s but used a different, unmarked hallway without measuring path length. What is the main reliability problem?
How should RPFT-level reliability thinking treat unsupervised home spirometry versus laboratory spirometry for a high-stakes clinical decision?